We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · December 07, 2021

Safety and Efficacy of Nab-Paclitaxel in Patients With Metastatic Breast Cancer With Visceral Metastases

BMC Cancer


Additional Info

BMC Cancer
Phase II trail of nab-paclitaxel in metastatic breast cancer patients with visceral metastases
BMC Cancer 2021 Nov 02;21(1)1174, Y Xie, C Gong, J Zhang, L Wang, J Cao, Z Tao, T Li, Y Zhao, Y Li, S Hu, B Wang, X Hu

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading